Prot# VEL-03-082: A Phase I/II Trial of Combination Bortezomib (VELCADE®) and Gemcitabine Therapy for Patients with Relapsed or Refractory Aggressive B- and T -Cell Non-Hodgkin's Lymphoma (NU Prot# NU 04H4)
- Mehta, Jayesh (Co-PD/PI)
- Singhal, Seema (Co-PD/PI)
- Platanias, Leonidas C (Co-PD/PI)
- Winter, Jane Norma (Co-PD/PI)
- Gordon, Leo I (Co-PD/PI)
- Gordon, Leo I (PD/PI)
- Williams, Stephanie Francesca (Co-PD/PI)
Project: Research project